Back to JNGHFView full pipeline
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Esophageal Squamous Cell Carcinoma
View Full LandscapeDrug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Camrelizumab plus TPPhase 3
Oral Squamous Cell Carcinoma
SHR7280 tabletsPhase 3
Female Subjects Undergoing COH in ART to Prevent Early Ovulation
Remimazolam Tosilate for injectionPhase 3
Operative Sedation of Pediatric
SHR7280；Ganirelix Acetate Injection simulantPhase 3
Infertile Female Subjects Undergoing Controlled Ovarian Hyperstimulation to Suppress Premature LH Surge and Prevent Early Ovulation
TACE+Camrelizumab+Apatinib mesylatePhase 3
Hepatocellular Carcinoma
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts